Hoshi Senji, Bilim Vladimir, Hoshi Kiyotsugu, Ogawa Yoshihiro, Kato Tomoyuki, Urano Kota, Yamada Tomoya, Sakagami Rie, Kudo Takashi, Numahata Kenji, Sasagawa Isoji
Department of Urology, Yamagata Tokushukai Hospital, Yamagata 990-0834, Japan.
Department of Urology, Kameda Daiichi Hospital, Niigata 950-0165, Japan.
J Pers Med. 2024 May 11;14(5):510. doi: 10.3390/jpm14050510.
Prostate cancer (PCa) ranks as the second most common cancer in Japanese males, while bladder cancer (BC) holds the tenth spot. Among double urological cancers, the incidence of synchronous or metachronous BC and PCa is the highest. Reports on upper urinary tract (UUT) urothelial cancer (UC) in PCa patients are limited. Here, we present three cases of metachronous PCa and BC, with subsequent diagnosis of ureteral and renal pelvic cancer during the course of the disease. In the follow-up of patients with urological cancers, it is important to be aware not only of the progression of the initial cancer but also the potential development of a second cancer.
前列腺癌(PCa)是日本男性中第二常见的癌症,而膀胱癌(BC)位居第十。在双重泌尿系统癌症中,同步或异时性膀胱癌和前列腺癌的发病率最高。关于前列腺癌患者上尿路(UUT)尿路上皮癌(UC)的报道有限。在此,我们报告三例异时性前列腺癌和膀胱癌病例,在疾病过程中随后诊断出输尿管和肾盂癌。在泌尿系统癌症患者的随访中,不仅要注意初始癌症的进展,还要注意第二种癌症的潜在发生,这一点很重要。